Nigella sativa-chitosan nanoparticles: Novel intestinal mucosal immunomodulator controls and protects against Salmonella enterica serovar Enteritidis infection in broilers

BMC Vet Res. 2023 Aug 1;19(1):103. doi: 10.1186/s12917-023-03632-1.

Abstract

Background: Salmonella Enteritidis (SE) propagates in chickens' gastrointestinal surfaces and is transmitted to humans, causing food poisoning. Oral supplementation with natural nanoparticles can overcome the harsh gastrointestinal conditions facing oral vaccines and requires no antibiotic administration to protect against microbial infection. This study was designed to study Nigella sativa-chitosan nanoparticles (CNP-NS) prophylactic immunomodulatory efficacy against SE infection in broiler chicks. The CNP-NS was prepared and characterized, and its in vivo immunomodulatory activities against an avian virulent-MDR SE-induced challenge in chicks were investigated.

Result: To verify the immune-protective activities of the CNP-NS, colony forming units (CFU) in the liver and fecal droppings; intestinal histopathological alterations and immune cell recruitment; MUC-2, TLR-4, cecal cytokines, and specific IgA gene expression levels were assessed. On the 7th and 12th days after the SE challenge, the CNP-NS supplemented chicks showed complete clearance of SE CFU in livers and fecal droppings, as well as an improvement in food conversion rate compared to non-supplemented CNP-NS that revealed the presence of the challenge SE CFU on the same days. A prominent influx of antigen presenting cells and lymphoid aggregates into the intestinal wall, spleen, and liver was detected with improvements in the intestinal villi morphometry of the CNP-NS-supplemented chicks. The changes of INF-γ, IL-1β, and IL-4 cecal cytokines, as well as TLR-4, MUC-2, and IgA mRNA expression levels, confirm CNP-NS immunomodulatory activities and provide a mechanism(s) for its protective actions against the induced SE challenge of the tested chickens.

Conclusion: These findings suggest promising useful insights into CNP-NS supplementation as a safe food additive for poultry meat consumers' and a protective immunomodulator of the chickens' mucosal immune systems. It could be recommended for epidemiological purposes to reduce the risk of SE food poisoning and transmission to humans.

Keywords: Chitosan; Food-borne diseases; Immunomodulation; Nanoparticles; Nigella sativa; Salmonella Enteritidis.

MeSH terms

  • Adjuvants, Immunologic
  • Animals
  • Chickens
  • Chitosan* / pharmacology
  • Cytokines / genetics
  • Foodborne Diseases* / veterinary
  • Humans
  • Immunoglobulin A
  • Immunologic Factors / pharmacology
  • Nanoparticles* / therapeutic use
  • Nigella sativa*
  • Poultry Diseases* / prevention & control
  • Salmonella Infections, Animal* / prevention & control
  • Salmonella enteritidis
  • Toll-Like Receptor 4

Substances

  • Chitosan
  • Toll-Like Receptor 4
  • Immunologic Factors
  • Cytokines
  • Adjuvants, Immunologic
  • Immunoglobulin A